Efficacy of Drug Therapy of Chronic Heart Failure in Young Children With Dilated Cardiomyopathy

Abstract

Dilated cardiomyopathy in children is a very serious disorder with a poor outcome. However, clinical practice has shown that young children have a higher capability to recover cardiac function, which requires an active approach to the prescription of drug therapy. Currently, the combined therapy of chronic heart failure, including ACE inhibitors, beta-blockers, aldosterone antagonists, diuretics, demonstrates high efficiency in reducing the severity of heart failure symptoms, and in improving or stabilizing laboratory and instrumental parameters. Early and adequate administration of drug therapy can improve the prognosis of the disease and prevent an adverse outcome.